Performance of Modified-EUCAST Rapid Direct Antimicrobial Susceptibility Testing on Clinical Urine Samples
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: The rapid antimicrobial susceptibility testing (AST) performed on urine samples would guide the adequate choice of antibiotics for obtaining better treatment outcomes in patients. Our study aimed to evaluate the performance of the modified-EUCAST (European Committee on Antimicrobial Susceptibility Testing) rapid direct AST on urine samples. Methods: From >2,000 urine samples, a total of 128 urine samples containing bacterial counts of ≥2 × 104 CFU/mL with a uniform bacterial shape were initially included based on flow cytometry (Sysmex UF-1000i, Japan) and Gram staining, respectively. A total of 103 samples showing the presence of Enterobacteriaceae were finally selected in this study. The urine samples were directly inoculated on Mueller-Hinton agar, which was used in the current EUCAST rapid direct AST on blood samples. The size of the growth inhibition zones around antimicrobial disks was measured using a digital scanner (BIOMIC vision analyzer, Giles scientific, USA) and further confirmed by visualization with naked eyes after incubation for 4, 6, and 8 hours. The AST interpretations were compared to those of the conventional VITEK 2 AST system (bioMérieux, France) and the discrepancies between both tests were confirmed with the E-test. Results: The antibiotics, namely ampicillin, cefazolin, aztreonam, ceftazidime, cefotaxime, cefoxitin, cefepime, gentamicin, ciprofloxacin, and cotrimoxazole showed excellent correlations with modified-EUCAST rapid direct test and conventional ASTs with >0.75 weighted kappa values. The categorical agreement of the rapid direct AST was 1,442 (93.3%), with 76 (4.9%) minor error, 9 (0.6%) major error and 18 (1.2%) very major error, implicating the reliability of this method for clinical application. Conclusion: Performing the modified-EUCAST rapid direct AST on urine samples can predict reliable AST results within 8 hours. The rapid direct AST can help the physicians to initiate adequate antimicrobial treatment for urinary tract infections.
Abstract
Background: The rapid antimicrobial susceptibility testing (AST) performed on urine samples would guide the adequate choice of antibiotics for obtaining better treatment outcomes in patients. Our study aimed to evaluate the performance of the modified-EUCAST (European Committee on Antimicrobial Susceptibility Testing) rapid direct AST on urine samples. Methods: From >2,000 urine samples, a total of 128 urine samples containing bacterial counts of ≥2 × 104 CFU/mL with a uniform bacterial shape were initially included based on flow cytometry (Sysmex UF-1000i, Japan) and Gram staining, respectively. A total of 103 samples showing the presence of Enterobacteriaceae were finally selected in this study. The urine samples were directly inoculated on Mueller-Hinton agar, which was used in the current EUCAST rapid direct AST on blood samples. The size of the growth inhibition zones around antimicrobial disks was measured using a digital scanner (BIOMIC vision analyzer, Giles scientific, USA) and further confirmed by visualization with naked eyes after incubation for 4, 6, and 8 hours. The AST interpretations were compared to those of the conventional VITEK 2 AST system (bioMérieux, France) and the discrepancies between both tests were confirmed with the E-test. Results: The antibiotics, namely ampicillin, cefazolin, aztreonam, ceftazidime, cefotaxime, cefoxitin, cefepime, gentamicin, ciprofloxacin, and cotrimoxazole showed excellent correlations with modified-EUCAST rapid direct test and conventional ASTs with >0.75 weighted kappa values. The categorical agreement of the rapid direct AST was 1,442 (93.3%), with 76 (4.9%) minor error, 9 (0.6%) major error and 18 (1.2%) very major error, implicating the reliability of this method for clinical application. Conclusion: Performing the modified-EUCAST rapid direct AST on urine samples can predict reliable AST results within 8 hours. The rapid direct AST can help the physicians to initiate adequate antimicrobial treatment for urinary tract infections.
참고문헌 (15)
- Mohammad RN, "Direct disk testing versus isolation and antimicrobial susceptibility testing of urine from urinary tract infection", Iran J Microbiol, 10, pp.37~44 (2018)
- Al-Naqshbandi AA, "Prevalence and antimicrobial susceptibility of bacterial pathogens isolated from urine specimens received in rizgary hospital-Erbil", J Infect Public Health, 12, pp.330~336 (2019)
- Sundqvist M, "EUCAST breakpoints can be used to interpret direct susceptibility testing of Enterobacteriaceae from urine samples", APMIS, 123, pp.152~155 (2015)
- Schoepp NG, "Rapid pathogen-specific phenotypic antibiotic susceptibility testing using digital LAMP quantification in clinical samples", Sci Transl Med, 9, pp.eaal3693~ (2017)
- Mishra P, "Advances in rapid detection and antimicrobial susceptibility tests : a review", Def Life Sci J, 4, pp.12~20 (2018)
- Paul S, "Evaluation of chromogenic agar and direct antimicrobial susceptibility testing in rapid diagnosis of acute urinary tract infection", Int J Pharm Clin Res, 7, pp.333~336 (2015)
- Eigner U, "Analysis of the comparative workflow and performance characteristics of the VITEK 2 and Phoenix systems", J Clin Microbiol, 43, pp.3829~3834 (2005)
- Perillaud C, "Prospective evaluation of rapid antimicrobial susceptibility testing by disk diffusion on Mueller-Hinton rapid-SIR directly on blood cultures", Diagn Microbiol Infect Dis, 93, pp.14~21 (2019)
- Coorevits L, "Direct susceptibility testing by disk diffusion on clinical samples : a rapid and accurate tool for antibiotic stewardship", Eur J Clin Microbiol, 34, pp.1207~1212 (2015)
- EUCAST, "EUCAST rapid antimicrobial susceptibility testing (RAST) directly from positive blood culture bottles. Version 1.1", ~ (2019)
- Clinical and Laboratory Standards Institute (CLSI), "Performance standards for antimicrobial susceptibility testing; 29th ed. CLSI supplement M100", ~ (2019)
- Fleiss JL, "Large sample standard errors of kappa and weighted kappa", Psychol Bull, 72, pp.323~327 (1969)
- Stokkou S, "Direct disk diffusion test using European clinical antimicrobial susceptibility testing breakpoints provides reliable results compared with the standard method", Eur J Microbiol Immunol, 5, pp.103~111 (2015)
- Breteler KB, "Performance and clinical significance of direct antimicrobial susceptibility testing on urine from hospitalized patients", Scand J Infect Dis, 43, pp.771~776 (2011)
- Perillaud-Dubois C, "Performance of rapid antimicrobial susceptibility testing by disk diffusion on MHR-SIR agar directly on urine specimens", Eur J Clin Microbiol Infect Dis, 38, pp.185~189 (2019)